The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-methoxy-4-((2-(naphthalen-2-yl)-5-oxooxazol-4(5H)-ylidene)methyl)phenyl acetate ID: ALA1668292
PubChem CID: 1722656
Max Phase: Preclinical
Molecular Formula: C23H17NO5
Molecular Weight: 387.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(/C=C2/N=C(c3ccc4ccccc4c3)OC2=O)ccc1OC(C)=O
Standard InChI: InChI=1S/C23H17NO5/c1-14(25)28-20-10-7-15(12-21(20)27-2)11-19-23(26)29-22(24-19)18-9-8-16-5-3-4-6-17(16)13-18/h3-13H,1-2H3/b19-11+
Standard InChI Key: XLXGKRFHMPAUSZ-YBFXNURJSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
9.1137 -4.0951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1126 -4.9224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8272 -5.3351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5435 -4.9219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5407 -4.0915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8254 -3.6823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2586 -5.3332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9298 -4.8535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3993 -3.6828 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3979 -5.3342 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.7127 -5.1153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2030 -4.4519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7234 -3.7805 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9365 -4.0298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6838 -4.9212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3991 -2.8580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6846 -2.4457 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1133 -2.4454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2730 -3.5398 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0277 -4.4584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4314 -5.1781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2555 -5.1850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4405 -3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2633 -3.7534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6734 -4.4728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4998 -4.4762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9167 -3.7609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5014 -3.0409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6764 -3.0410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14 8 1 0
4 7 1 0
10 15 1 0
3 4 2 0
9 16 1 0
7 8 2 0
16 17 2 0
16 18 1 0
1 9 1 0
14 19 2 0
4 5 1 0
12 20 1 0
2 10 1 0
20 21 2 0
8 11 1 0
21 22 1 0
22 25 2 0
2 3 1 0
24 23 2 0
23 20 1 0
5 6 2 0
6 1 1 0
24 25 1 0
1 2 2 0
25 26 1 0
11 12 2 0
26 27 2 0
12 13 1 0
27 28 1 0
13 14 1 0
28 29 2 0
29 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 387.39Molecular Weight (Monoisotopic): 387.1107AlogP: 4.12#Rotatable Bonds: 4Polar Surface Area: 74.19Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.28CX LogD: 4.28Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.38Np Likeness Score: -0.48
References 1. Chu Y, Chen X, Yang Y, Tang Y.. (2011) Identification of small molecular inhibitors for Ero1p by structure-based virtual screening., 21 (4): [PMID:21269829 ] [10.1016/j.bmcl.2010.12.129 ]